Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

Vaccines have been protecting against disease since the late 1700s. They function by triggering the immune system to generate short-term and long-term responses. Because there are many pathogens, ...

Figure 1: (a) Cell and gene therapy development pathway from patient/donor (red) to recipient (blue); (b) subcellular molecules and ions important for effective cell and gene therapy cultures ...

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

Explore the latest news and expert commentary on CMC Forums, brought to you by the editors of BioProcess International ...

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

As I look forward to retirement and revisit 35 years in publishing, I marvel at all the adventures that a graduate degree in comparative literature can lead to. I’d always dabbled in biology, but for ...

This two-part review provides high-level analytical development considerations for ex vivo, genome-modified hematopoietic stem and progenitor cell (GM-HSPC) products derived from primary donor cells.

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

Explore the latest news and expert commentary on Microbial Cell Culture, brought to you by the editors of BioProcess International ...

In the 24th year of this millennium, the biopharma sector navigated seismic shifts, from legislative challenges and technological advancements to restructuring and landmark acquisitions. Together, ...